Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2023 Jun 1:247:109873.
doi: 10.1016/j.drugalcdep.2023.109873. Epub 2023 Apr 12.

A randomized clinical trial testing two implementation strategies to promote the treatment of tobacco dependence in community mental healthcare

Robert A Schnoll  1 , Frank T Leone  2 , Mackenzie Hosie Quinn  3 , Nathaniel Stevens  3 , Alex Flitter  3 , Paul Wileyto  3 , John Kimberly  4 , Rinad S Beidas  5 , Jane Hatzell  3 , Scott D Siegel  6 , Grace Crawford  3 , Naja Hill  3 , Teresa Deatley  3 , Douglas Ziedonis  7
Affiliations
Randomized Controlled Trial

A randomized clinical trial testing two implementation strategies to promote the treatment of tobacco dependence in community mental healthcare

Robert A Schnoll et al. Drug Alcohol Depend. .

Abstract

Introduction: People with serious mental illness (SMI) are more likely to smoke and less likely to receive tobacco treatment. Implementation strategies may address clinician and organizational barriers to treating tobacco in mental healthcare.

Methods: A cluster-randomized trial (Clinic N=13, Client N=610, Staff N=222) tested two models to promote tobacco treatment in community mental healthcare: standard didactic training vs. Addressing Tobacco Through Organizational Change (ATTOC), an organizational model that provides clinician and leadership training and addresses system barriers to tobacco treatment. Primary outcomes were changes in tobacco treatment from clients, staff, and medical records. Secondary outcomes were changes in smoking, mental health, and quality of life (QOL), and staff skills and barriers to treat tobacco.

Results: Clients at ATTOC sites reported a significant increase in receiving tobacco treatment from clinician at weeks 12 and 24 (ps<0.05) and tobacco treatments and policies from clinics at weeks 12, 24, 36, and 52 (ps<0.05), vs. standard sites. ATTOC staff reported a significant increase in skills to treat tobacco at week 36 (p=0.05), vs. standard sites. For both models, tobacco use medications, from clients (week 52) and medical records (week 36), increased (ps<0.05), while perceived barriers decreased at weeks 24 and 52 (ps<0.05); 4.3% of clients quit smoking which was not associated with model. QOL and mental health improved over 24 weeks for both models (ps<0.05).

Conclusions: Standard training and ATTOC improve use of evidence-based tobacco treatments in community mental healthcare without worsening mental health, but ATTOC may more effectively address this practice gap.

Keywords: Implementation; Mental health; Tobacco treatment; Training.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest Dr. Schnoll has received medication and placebo free from Pfizer and has provided consultation to Pfizer, GlaxoSmithKline, and Curaleaf. Dr. Beidas is principal at Implementation Science & Practice, LLC. She receives royalties from Oxford University Press, consulting fees from United Behavioral Health and OptumLabs, and serves on the advisory boards for Optum Behavioral Health, AIM Youth Mental Health Foundation, and the Klingenstein Third Generation Foundation outside of the submitted work.

Figures

Figure 1.
Figure 1.
CONSORT Diagram
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Cornelius ME, Loretan CG, Wang TW, Jamal A, Homa DM. Tobacco product use among adults-United States, 2020. Morbidity and Mortality Weekly Report. 2022;71. - PMC - PubMed
    1. Ku L, Bruen BK, Steinmetz E, Bysshe T. Medicaid tobacco cessation: Big gaps remain in efforts to get smokers to quit. Health Aff (Millwood). 2016;35(1):62–70. doi:10.1377/hlthaff.2015.0756 - DOI - PMC - PubMed
    1. Jarlenski M, Hyon Baik S, Zhang Y. Trends in use of medications for smoking cessation in Medicare, 2007–2012. Am J Prev Med. 2016;51(3):301–308. doi:10.1016/j.amepre.2016.02.018 - DOI - PMC - PubMed
    1. Jamal A, Dube SR, King BA. Peer Reveiwed: Tobacco Use Screening and Counseling During Hospital Outpatient Visits Among US Adults, 2005–2010. Preventing Chronic Disease. 2005;12. - PMC - PubMed
    1. Huang Y, Britton J, Hubbard R, Lewis S. Who receives prescriptions for smoking cessation medications? An association rule mining analysis using a large primary care database. Tob Control. 2013;22(4):274–279. doi:10.1136/tobaccocontrol-2011-050124 - DOI - PubMed

Publication types